SEC Filings

Form F-1
AURIS MEDICAL HOLDING AG filed this Form F-1 on 10/12/2017
Document Outline
Entire Document (542.1 KB)
Subdocument 1 - F-1 - FORM F-1
Page 1 - Filed with the Securities and Exchange Commission on October 12, 2017
Page 2 - PRELIMINARY PROSPECTUS
Page 3 - table of contents
Page 4 - This summary highlights information contained elsewhere in this prospectus. This summary may not con
Page 5 - Recent Developments
Page 6 - Clinical and Other Developments
Page 7 - N/A
Page 8 - This summary highlights information presented in greater detail elsewhere in this prospectus. This s
Page 9 - N/A
Page 10 - Any investment in our common shares involves a high degree of risk. You should carefully consider th
Page 11 - In the event that our common shares are delisted from Nasdaq, U.S. broker-dealers may be discouraged
Page 12 - N/A
Page 13 - N/A
Page 14 - N/A
Page 15 - N/A
Page 16 - N/A
Page 17 - General
Page 18 - Termination Rights
Page 19 - N/A
Page 20 - Gewinnvortrag
Page 21 - N/A
Page 22 - N/A
Page 23 - N/A
Page 24 - Aktiengesellschaft
Page 25 - Bezugsrechte
Page 26 - Erm chtigungsbeschluss
Page 27 - according to one or several equity incentive plans or regulations issued by the Board of Directors.
Page 28 - N/A
Page 29 - Gewinnvortrag
Page 30 - Wertrechte
Page 31 - N/A
Page 32 - N/A
Page 33 - N/A
Page 34 - N/A
Page 35 - Schweizerisches Obligationenrecht)
Page 36 - N/A
Page 37 - N/A
Page 38 - N/A
Page 39 - N/A
Page 40 - N/A
Page 41 - The following summary contains a description of the material Swiss and U.S. federal income tax conse
Page 42 - Sitzgesellschaft
Page 43 - Nennwertr ckzahlungen
Page 44 - Beteiligungsabzug
Page 45 - N/A
Page 46 - de minimis
Page 47 - pro rata
Page 48 - N/A
Page 49 - N/A
Page 50 - N/A
Page 51 - N/A
Page 52 - N/A
Page 53 - N/A
Page 54 - N/A
Page 55 - N/A
Page 56 - N/A
Page 57 - N/A
Page 58 - N/A
Page 59 - N/A
Page 60 - N/A
Page 61 - N/A
Page 62 - NAME
Subdocument 2 - EX-5.1 - EXHIBIT 5.1
Page 1 - EXHIBIT 5.1
Page 2 - Documents
Page 3 - AGM Resolution
Page 4 - N/A
Page 5 - N/A
Page 6 - N/A
Subdocument 3 - EX-23.1 - EXHIBIT 23.1
Page 1 - EXHIBIT 23.1